US Patent Issued to NATIONAL CENTER OF NEUROLOGY AND PSYCHIATRY, CHUGAI SEIYAKU on Dec. 30 for "Method for predicting and evaluating therapeutic effect in diseases related to IL-6 and neutrophils" (Japanese Inventors)

ALEXANDRIA, Va., Dec. 31 -- United States Patent no. 12,509,511, issued on Dec. 30, was assigned to NATIONAL CENTER OF NEUROLOGY AND PSYCHIATRY (Tokyo) and CHUGAI SEIYAKU K.K. (Tokyo).

"Method for predicting and evaluating therapeutic effect in diseases related to IL-6 and neutrophils" was invented by Takako Matsuoka (Tokyo), Manabu Araki (Tokyo) and Takashi Yamamura (Tokyo).

According to the abstract* released by the U.S. Patent & Trademark Office: "It has become clear that the therapeutic effect of an IL-6 inhibitor for IL-6- and neutrophil-associated diseases can be predicted using the expression level of neutrophil-associated genes as an indicator. It has also become clear that an IL-6 inhibitor is effective for the treatment of IL-6-...